| Literature DB >> 27052303 |
Rodrigo Fernandez-Gonzalo1, Sol Fernandez-Gonzalo2, Marc Turon2,3, Cristina Prieto4,5, Per A Tesch6, Maria del Carmen García-Carreira7.
Abstract
BACKGROUND: Resistance exercise (RE) improves neuromuscular function and physical performance after stroke. Yet, the effects of RE emphasizing eccentric (ECC; lengthening) actions on muscle hypertrophy and cognitive function in stroke patients are currently unknown. Thus, this study explored the effects of ECC-overload RE training on skeletal muscle size and function, and cognitive performance in individuals with stroke.Entities:
Keywords: Eccentric overload; Executive function; Muscle hypertrophy; Muscle-brain interaction
Mesh:
Year: 2016 PMID: 27052303 PMCID: PMC4823904 DOI: 10.1186/s12984-016-0144-7
Source DB: PubMed Journal: J Neuroeng Rehabil ISSN: 1743-0003 Impact factor: 4.262
Fig. 1CONSORT flow diagram. * see text for specific number of participants analyzed for each test
Fig. 2Stroke patient performing resistance exercise on a flywheel leg press device
Fig. 3Magnetic resonance images showing thigh muscles (mid-thigh level) of more-affected (R) and less-affected (L) limbs of individual with stroke before (PRE) and after (POST) 12 weeks of ECC-overload flywheel RE training. Quadriceps femoris muscles denoted by numbers are: 1 m. rectus femoris, 2 m. vastus lateralis, 3 m. vastus intermedius, 4 m. vastus medialis. In this particular individual, m. quadriceps femoris volume of more-affected, trained limb increased by 11.8 %
Baseline characteristics of participants in training group (TG) and control group (CG)
| TG ( | CG ( | Student’s | |
|---|---|---|---|
| Age (yr) | 61.2 (9.8) | 65.7 (12.7) | 1.06 ( |
| Height (cm) | 165.6 (9.7) | 169.3 (9.7) | 1.03 ( |
| Weight (kg) | 80.4 (15.3) | 83.4 (16.0) | 0.51 ( |
| Time since stroke (yr) | 3.5 (3.6) | 4.3 (4.9) | 0.96 ( |
| Time under scholarization (yr) | 8.9 (3.5) | 8.3 (3.6) | 0.45 ( |
| Mini-Mental State Examination (a.u) | 28.1 (1.8) | 27.7 (2.3) | 0.53 ( |
| Hospital Anxiety and Depression Scale (Depression) | 6.5 (3.7) | 5.5 (3.7) | <0.01 ( |
| Hospital Anxiety and Depression Scale (Anxiety) | 6.5 (5.1) | 7.2 (4.4) | 0.69 ( |
| Sex (female/male) | 3/11 | 4/11 | 0.11 ( |
| Mechanism of stroke (hemorrhagic/ischemic) | 5/9 | 4/11 | 0.28 ( |
| Localization (cortical/subcortical) | 7/7 | 5/10 | 0.83 ( |
| Hemispheric lateralization (right/left) | 5/9 | 10/5 | 4.69 ( |
| Marital status (single/married/divorced) | 2/9/2 | 0/14/1 | 4.40 ( |
| Dominant side (right/left) | 14/0 | 14/1 | 0.97 ( |
Note: To compare baseline values between training group and control group, Student’s t-test was used for quantitative variables and Chi-squared test for qualitative variables
Isometric and dynamic force, peak power, quadriceps femoris (QF) muscles volume and cross sectional area (CSA) in the training group (TG) and the control group (CG) before (PRE) and after (POST) the 12-week eccentric-overload flywheel resistance exercise intervention
| More-affected leg | Less-affected leg | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| PRE | POST | Δ % | 95 % CI | PRE | POST | Δ % | 95 % CI | ||
| Maximal isometric force (N) | |||||||||
| TG c,d | 714.3 (314.4) | 856.1 (386.2) # | 19.8 | 58.03 to 225.47 | 1128.4 (355.8) * | 1148.5 (364.0) * | 1.8 | -108.05 to 148.23 | |
| CG d | 653.4 (327.7) | 626.0 (269.7) | -4.2 | -108.70 to 53.89 | 989.1 (363.4) * | 983.9 (315.5) * | -0.5 | -104.60 to 94.11 | |
| Maximal dynamic force (N) a | |||||||||
| TG c | 481.8 (166.3) | 548.5 (190.4) | 13.8 | -1.23 to 134.63 | 520.5 (192.2) | 570.3 (176.2) | 9.6 | -10.74 to 110.45 | |
| CG d | 454.9 (146.9) | 431.2 (133.0) | -5.2 | -64.07 to 16.71 | 538.6 (203.3) | 545.1 (194.0) | 1.2 | -37.73 to 50.58 | |
| Peak power (W) a | |||||||||
| TG c,d | 89.4 (66.4) | 132.5 (87.6) # | 48.2 | 23.25 to 62.92 | 161.3 (101.7) * | 206.7 (117.6) #* | 28.1 | 15.89 to 74.91 | |
| CG b,c,d | 92.7 (50.4) | 98.1 (55.2) | 5.9 | -4.48 to 15.37 | 150.3 (66.8) * | 169.6 (66.3) #* | 12.9 | 6.14 to 32.51 | |
| QF muscle volume (cm3) a | |||||||||
| TG b,c,d | 665.4 (260.0) | 727.9 (283.6) # | 9.4 | 37.68 to 87.44 | 806.3 (263.8) * | 810.1 (260.8) * | 0.5 | -25.53 to 33.12 | |
| CG d | 755.6 (258.9) | 757.8 (256.9) | 0.3 | -26.37 to 30.77 | 861.4 (285.1) * | 859.0 (275.3) * | -0.3 | -28.47 to 23.59 | |
| RF muscle volume (cm3) | |||||||||
| TG d | 70.0 (35.4) | 70.1 (32.7) | 0.1 | -5.13 to 5.33 | 78.6 (34.7) | 79.9 (33.8) | 1.7 | -3.04 to 5.69 | |
| CG | 67.9 (29.5) | 70.3 (30.4) | 3.5 | 0.17 to 4.58 | 70.6 (29.3) | 72.5 (30.1) | 2.7 | -1.54 to 5.33 | |
| VL muscle volume (cm3) a | |||||||||
| TG b,c,d | 230.4 (90.2) | 253.5 (96.9) # | 10.0 | 13.71 to 32.54 | 275.3 (85.3) * | 275.6 (84.3) | 0.1 | -13.16 to 13.91 | |
| CG d | 263.9 (93.4) | 262.7 (89.6) | -0.5 | -14.36 to 11.88 | 311.2 (118.5) * | 308.1 (108.8) * | -1.0 | -14.80 to 8.67 | |
| VI muscle volume (cm3) | |||||||||
| TG b,c,d | 193.2 (79.7) | 213.2 (93.6) # | 10.3 | 7.66 to 32.33 | 240.1 (81.4) * | 239.4 (86.8) * | -0.3 | -9.84 to 8.53 | |
| CG d | 226.7 (90.3) | 234.1 (93.9) | 3.3 | -2.17 to 16.98 | 255.1 (96.8) * | 254.0 (98.1) | -0.4 | -9.03 to 6.95 | |
| VM muscle volume (cm3) a | |||||||||
| TG b,c,d | 171.8 (68.8) | 191.2 (71.5) # | 11.3 | 12.30 to 26.39 | 212.4 (83.0) * | 215.2 (76.9) * | 1.3 | -5.02 to 10.53 | |
| CG b,d | 194.4 (70.5) | 187.9 (63.9) | -3.3 | -16.76 to 3.76 | 222.5 (68.3) * | 224.2 (69.6) * | 0.8 | -5.90 to 9.38 | |
| QF greatest CSA (cm2) a | |||||||||
| TG b,c,d | 53.2 (14.2) | 57.6 (14.8) # | 8.2 | 2.17 to 6.52 | 62.6 (13.1) * | 63.7 (14.2) * | 1.8 | -0.83 to 3.06 | |
| CG d | 57.5 (16.7) | 56.3 (15.9) | -2.0 | -3.00 to 0.71 | 64.8 (15.8) * | 64.6 (15.5) * | -0.3 | -1.73 to 1.34 | |
| QF mean CSA (cm2) a | |||||||||
| TG b,c,d | 48.7 (13.1) | 53.2 (14.3) # | 9.3 | 3.06 to 6.04 | 57.7 (13.1) * | 58.6 (13.3) * | 1.6 | -0.67 to 2.47 | |
| CG d | 52.6 (14.8) | 52.1 (14.3) | -1.0 | -2.04 to 1.01 | 59.4 (14.4) * | 59.2 (14.0) * | -0.3 | -1.69 to 1.37 | |
Note. 95 % CI; 95 % confidence interval for the Post-Pre difference in absolute values within a group. QF; quadriceps femoris, RF; rectus femoris, VL; vastus lateralis, VI; vastus intermedius, VM; vastus medialis. Significant main effects (P < 0.05); a interaction group x time; b interaction time x leg; c main effect of time; d main effect of leg. Significant simple effects (P < 0.05); #vs. pre value within a leg; *vs. more-affected leg for a given time point
Functional and cognitive variables in training group (TG) and control group (CG) before (PRE) and after (POST) the 12-week eccentric-overload flywheel resistance exercise intervention
| TG | CG | |||||||
|---|---|---|---|---|---|---|---|---|
| n | PRE | POST | Dif (95 % CI) | n | PRE | POST | Dif (95 % CI) | |
| Spasticity (a.u.) | 14 | 1.18 (0.88) | 0.94 (0.71) | -0.24 (-0.51 to 0.03) | 15 | 0.79 (0.89) | 0.65 (0.71) | -0.13 (-0.40 to 0.14) |
| Berg Balance Scale (a.u.) a, b | 14 | 42.2 (9.5) | 45.9 (9.1) # | 3.77 (2.60 to 4.94) | 15 | 45.6 (8.7) | 44.0 (9.6) # | -1.64 (-2.77 to -0.51) |
| Timed-Up-and-Go (s) a, b | 14 | 20.3 (14.5) | 18.2 (13.9) # | -2.16 (-3.67 to -0.65) | 15 | 17.6 (16.0) | 17.6 (14.8) | 0.03 (-1.42 to 1.49) |
| Single-task circuit time (s) b | 14 | 44.4 (33.4) | 40.0 (33.5) # | -4.39 (-7.48 to -1.30) | 15 | 34.7 (30.4) | 33.2 (26.0) | -1.45 (-4.42 to 1.53) |
| Dual-task circuit time (s) a | 12 | 53.5 (47.4) | 46.3 (43.5) | -7.19 (-13.07 to -1.31) | 14 | 34.5 (18.5) | 36.8 (20.5) | 2.30 (-3.58 to 8.19) |
| Dual-task cost of walking (a.u.) a | 12 | 23.8 (19.7) | 17.0 (13.9) | -6.76 (-15.31 to 1.80) | 14 | 27.1 (23.0) | 35.4 (31.2) | 8.33 (0.15 to 16.53) |
| Digits Span Forward (a.u.) a | 12 | 7.2 (2.7) | 7.4 (2.1) | 0.25 (-0.45 to 0.95) | 14 | 7.0 (1.8) | 6.7 (2.1) | -0.29 (-0.93 to 0.36) |
| Digits Span Backward (a.u.) a | 12 | 4.0 (2.2) | 4.7 (1.6) | 0.67 (-0.10 to 1.44) | 14 | 4.8 (1.5) | 4.4 (1.7) | -0.36 (-1.07 to 0.35) |
| RAVLT Learning (a.u.) | 12 | 35.8 (7.7) | 38.3 (8.3) | 2.50 (-1.52 to 6.52) | 13 | 37.2 (11.1) | 35.8 (11.8) | -1.46 (-5.32 to 2.40) |
| RAVLT Long-term Recall (a.u.) | 12 | 6.2 (2.7) | 5.6 (3.3) | -0.58 (-1.85 to 0.69) | 13 | 6.6 (3.4) | 6.5 (3.9) | -0.08 (-1.30 to 1.14) |
| CPT Reaction Time (a.u.) | 14 | 465.4 (95.6) | 457.4 (89.6) | -7.93 (-31.95 to 16.08) | 15 | 447.8 (94.9) | 443.8 (82.1) | -4.01 (-27.21 to 19.20) |
| Spatial Span Forward (a.u.) | 14 | 6.2 (1.8) | 6.9 (2.2) | 0.64 (-0.24 to 1.53) | 15 | 6.9 (1.6) | 6.5 (1.9) | -0.33 (-1.19 to 0.52) |
| Spatial Span Backward (a.u.) | 14 | 5.4 (2.1) | 5.7 (1.8) | 0.29 (-0.50 to 1.07) | 15 | 6.1 (2.1) | 6.1 (2.2) | -0.07 (-0.83 to 0.70) |
| Stroop Word (a.u.) | 13 | 74.5 (20.7) | 72.1 (22.3) | -2.46 (-14.29 to 9.37) | 13 | 81.2 (22.6) | 71.7 (30.5) | -9.46 (-21.29 to 2.37) |
| Stroop Color (a.u.) a | 13 | 47.2 (18.2) | 48.6 (18.0) # | 1.46 (-1.85 to 4.78) | 13 | 55.9 (14.8) | 54.9 (15.9) | -1.00 (-4.32 to 2.32) |
| Stroop Word and Color (a.u.) | 13 | 21.6 (12.8) | 22.8 (13.9) | 1.15 (-2.29 to 4.60) | 13 | 27.5 (12.8) | 29.2 (12.2) | 1.69 (-1.76 to 5.14) |
| TMT_A (a.u.) | 13 | 71.6 (29.7) | 65.9 (35.1) | -5.77 (-19.15 to 7.61) | 15 | 71.9 (48.4) | 67.2 (38.8) | -4.67 (-17.13 to 7.79) |
| TMT_B (a.u.) | 10 | 206.7 (109.1) | 196.6 (129.7) | -10.10 (-42.10 to 21.90) | 10 | 183.2 (165.3) | 186.0 (141.9) | 2.80 (-29.20 to 34.80) |
| FAS (a.u.) a | 13 | 21.9 (14.3) | 26.6 (15.3) # | 4.69 (0.88 to 8.51) | 13 | 25.5 (13.5) | 25.4 (15.6) | -0.15 (-3.97 to 3.66) |
| SF-36 Physical function (a.u.) | 13 | 33.1 (21.8) | 38.9 (28.4) | 5.77 (-6.16 to 17.70) | 15 | 38.3 (25.6) | 44.0 (32.8) | 5.67 (-5.44 to 16.77) |
| SF-36 Physical limitation (a.u.) | 13 | 50.5 (39.6) | 65.9 (31.9) | 15.39 (-2.73 to 33.50) | 15 | 63.3 (40.5) | 62.9 (39.6) | -0.42 (-17.28 to 16.45) |
| SF-36 Pain (a.u.) a | 13 | 65.2 (36.2) | 76.9 (23.1) | 11.73 (-6.16 to 29.62) | 15 | 67.3 (39.6) | 49.8 (39.1) * # | -17.50 (-34.16 to -0.85) |
| SF-36 Social function (a.u.) | 13 | 82.7 (19.8) | 85.8 (20.1) | 3.08 (-10.47 to 16,63) | 15 | 76.7 (29.1) | 78.3 (31.5) | 1.67 (-10.95 to 14.28) |
| SF-36 Mental health (a.u.) b | 13 | 61.9 (23.6) | 78.1 (15.9) | 16.15 (3.02 to 29.29) | 15 | 66.3 (22.6) | 71.4 (24.7) | 5.02 (-7.22 to 17.24) |
| SF-36 Emotional problems limitation (a.u.) | 13 | 79.5 (22.7) | 89.1 (23.2) | 9.62 (-6.71 to 25.94) | 15 | 93.3 (19.9) | 87.8 (30.9) | -5.56 (-20.75 to 9.64) |
| SF-36 Vitality (a.u.) | 13 | 53.9 (20.3) | 55.3 (26.9) | 1.44 (-14.02 to 16.91) | 15 | 51.0 (23.5) | 52.1 (30.9) | 1.08 (-13.31 to 15.48) |
| SF-36 General perception (a.u.) | 13 | 56.5 (17.9) | 58.5 (19.9) | 1.92 (-7.41 to 11.26) | 15 | 54.0 (22.4) | 51.7 (18.9) | -2.33 (-11.02 to 6.36) |
Note: n; number of participants, RAVLT; Rey Auditory Verbal Learning Test, CPT; Continuous Performance Test, TMT; Trail Making Test, FAS; Verbal Fluency Test, SF-36; quality of life scale, a.u.; arbitrary units, s; seconds, Dif (95 % CI); Post-Pre difference (95 % confidence interval). Significant main effects (P < 0.05); a interaction group x time; b main effect of time. Significant simple effects (P < 0.05); #vs. pre value within group, *vs TG within a time point
Fig. 4Merged concentric-eccentric leg press peak power (W) of the more-affected limb over 24 training sessions. Significant main effects (P < 0.001); b = main effect of session. Data presented as mean ± standard error